Search for: "Anda Pharmaceuticals, Inc" Results 321 - 340 of 606
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Feb 2011, 5:35 pm by FDABlog HPM
  Another, subsequent ANDA sponsor, Sun Pharmaceuticals, obtained tentative approval for its ANDA No. 78-433 on March 4, 2008. [read post]
1 Aug 2011, 8:19 am
The seven defendants, Actavis Elizabeth LLC, Sun Pharmaceuticals, Sandoz Inc., Mylan Pharmaceuticals, Apotex Inc., Aurobindo Pharma Ltd., and Teva Pharmaceuticals, had filed an Abbreviated New Drug Application (ANDA) seeking to utilize Lilly's patented formula and claiming invalidity of Lilly's patent, No. 5,658,590, Treatment of attention-deficit/hyperactivity disorder, which has been issued by the US Patent Office. [read post]
26 May 2015, 12:53 pm
., Ltd. of Tokyo, Japan; Daiichi Sankyo, Inc. of Parsippany, New Jersey; and Ube Industries, Ltd of Yamaguchi, Japan filed a federal lawsuit in the Southern District of Indiana alleging that HEC Pharm USA, Inc. of Princeton, New Jersey and HEC Pharm Co. [read post]
28 Sep 2012, 11:15 am by Todd M. Nosher
Watson Pharmaceuticals, Inc., No. 10-12729, where the Eleventh Circuit upheld reverse payments -- finding no antitrust violation in settlements involving generic Androgel. [read post]
5 Sep 2012, 5:45 pm
California - The Federal Circuit on Tuesday gave Santarus Inc. another chance to prove that its patents for the heartburn drug Zegerid are valid and that Par Pharmaceuticals Inc.'s proposed generic version would infringe those patents. [read post]
29 Apr 2015, 11:15 am
This lawsuit adds another two new Defendants, Lupin Ltd. and Lupin Pharmaceuticals, Inc. [read post]
19 May 2011, 9:12 pm
Teleflex, Inc., 550 U.S. 398, 421 (2007). [read post]